Daniel S. Herman, MD, PhD, is one of eight recipients of this year’s College of American Pathologists (CAP) Foundation Leadership Development Award. The annual award is bestowed on junior pathologists who show great promise as the physicians that diagnose and study disease. The award provides a stipend for the recipients so that they may attend pathology meetings, immerse themselves in the issues affecting the specialty and its patients, and become leaders of their field. Dr. Herman, an Assistant Professor of Pathology and Laboratory Medicine, received his MD and PhD in genetics from Harvard University and completed a residency in clinical pathology at the University of Washington. He plans to learn more about the detailed regulation process and engage in further health care advocacy projects. Dr. Herman is also a recipient of a 2016 Thomas B. McCabe and Jeannette E. Laws McCabe Fund at the Perelman School of Medicine in support of junior faculty who initiate innovative biomedical and surgical research projects.

Kathleen Montone, MD, is one of twenty volunteers to serve as digital slide consultants for the Butaro Hospital Telepathology Team in a global health initiative by the American Society of Clinical Pathology (ASCP). Butaro Disctrict Hospital is in the city of Butaro in northern Rwanda and has no permanent pathologist on site. With the assembled group, the ASCP will be able to provide high-quality, rapid secondary consultations on cases as well as offer teaching opportunities to local residents. The ASCP efforts are part of a White House/Clinton Global Initiative to provide patients in underserved areas of Sub-Saharan Africa access to rapid cancer diagnostics and appropriate care and treatment.

Irving Nachamkin, DrPH, MPH, D(ABMM), FAAM, FIDSA, has been appointed to a three-year term as a member of the Publications Committee for the Infectious Diseases Society of America (ISDA). The IDSA Publications Committee oversees the society’s scientific journals, the Journal of Infectious Diseases and Clinical Infectious Diseases, and makes recommendations to the IDSA Board of Directors on substantive editorial policy issues and financial matters.